Robert Kuhling
General Partner and Managing Director @ ONSET Ventures
Menlo Park, United States
Robert Kuhling is a Series C investor at ONSET Ventures in Menlo Park focused on Health Care and Biotechnology. Rob Kuhling came to ONSET Ventures in 1987 after experience in a variety of technology marketing, strategic development and management positions. Rob was Director of Marketing at Sun Microsystems, where he spearheaded the company’s expansion into the design automation marketplace. He also served as VP and Manager of General Electric-Calma’s$100 million electronic design automation business and was a team leader for Boston Consulting Group, where he oversaw the development of a range of corporate business strategies.At ONSET Ventures, Rob invests in communications and networking companies and medical device companies. Rob serves on the boards of several public and private companies, and has led ONSET Ventures’ investments in companies like Aneurx, Clarify, Conceptus, Alteon, Packeteer, Embolic Protection, Endotex Interventional Systems, and Gadzoox Networks. Rob’s current board memberships are Access Closure, Baronova, ClariPhy Communications and Uptake Medical.Rob received his A.B. from Hamilton College and his MBA from Harvard Business School.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Robert Kuhling invests in
Stages Robert Kuhling invests in
Countries Robert Kuhling invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (33%)
- Biotechnology 2 (22%)
- Medical Device 2 (22%)
- Medical 1 (11%)
- Semiconductor 1 (11%)
Stage
- Series C 3 (33%)
- Series B 2 (22%)
- Funding Round 2 (22%)
- Series D 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BAROnova, founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss. | $36.5M / Series D / Nov 23, 2015 | ||
| ClariPhy Communications is a fabless semiconductor company that develops mixed-signal CMOS integrated circuits for optical networking and communication applications. It offers CL1011, a XAUI-based Ethernet transceiver for enterprise networks and data centers; and CL1012, a clock and data recovery integrated circuit for metro and long haul telecomnetworks. The company's customers include OEMs of networking equipment, such as switches, servers, and optical modules. It serves various markets, including enterprise local area networks, enterprise data centers, and telecom wide area networks. ClariPhy Communications was founded in 2002 and is based in Irvine, California with an additional office in Los Altos, California. | $19.7M / Aug 13, 2014 | ||
| BAROnova, founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss. | Series C / Feb 15, 2013 | ||
| Access Closure, Inc., a medical device company, provides access site management products to address the complex challenge of vascular closure during interventional and diagnostic procedures. The company's products include Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble and extravascular sealant,which expands in the tissue tract by absorbing blood and subcutaneous fluids. Access Closure, Inc. was founded in 2002 and is based in Mountain View, California. | $998.1K / Oct 01, 2012 | ||
| Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor™, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body’s natural healing process without leaving any foreign materials in the lung. In clinical studies,InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life. | Series C / Mar 13, 2012 | ||
| ClariPhy Communications is a fabless semiconductor company that develops mixed-signal CMOS integrated circuits for optical networking and communication applications. It offers CL1011, a XAUI-based Ethernet transceiver for enterprise networks and data centers; and CL1012, a clock and data recovery integrated circuit for metro and long haul telecomnetworks. The company's customers include OEMs of networking equipment, such as switches, servers, and optical modules. It serves various markets, including enterprise local area networks, enterprise data centers, and telecom wide area networks. ClariPhy Communications was founded in 2002 and is based in Irvine, California with an additional office in Los Altos, California. | $14M / Series C / Jun 20, 2011 | ||
| Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor™, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body’s natural healing process without leaving any foreign materials in the lung. In clinical studies,InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life. | Series B / Jul 07, 2010 | ||
| ClariPhy Communications is a fabless semiconductor company that develops mixed-signal CMOS integrated circuits for optical networking and communication applications. It offers CL1011, a XAUI-based Ethernet transceiver for enterprise networks and data centers; and CL1012, a clock and data recovery integrated circuit for metro and long haul telecomnetworks. The company's customers include OEMs of networking equipment, such as switches, servers, and optical modules. It serves various markets, including enterprise local area networks, enterprise data centers, and telecom wide area networks. ClariPhy Communications was founded in 2002 and is based in Irvine, California with an additional office in Los Altos, California. | $24M / Series C / May 27, 2010 | ||
| BAROnova, founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss. | Series B / Oct 23, 2008 |
Co-Investors
About ONSET Ventures
ONSET Ventures is a private equity firm that offers early- and later-stage investment services to firms in the IT and medical technology industries. It was founded by David Kelley, Michael Levinthal, and Terry Opdendyk and is based in California.
ONSET Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Robert Kuhling
General Partner and Managing Director
|
|||
Beatrice Pezino
CFO
|
|||
Jennifer Lewis
Vice President of Marketing & Communications
|
|||
John Ryan
Managing Director & Partner
|
|||
Rick Schell
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Robert Kuhling invest in?
Robert Kuhling invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series C and Series B stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Robert Kuhling?
Public channels for Robert Kuhling include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Robert Kuhling last invest?
The most recent investment recorded for Robert Kuhling closed in Nov 2015. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
